Monte Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Monte Rosa Therapeutics
GLUE Stock  USD 5.78  0.06  1.03%   
Monte Rosa financial statements provide useful quarterly and yearly information to potential Monte Rosa Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Monte Rosa financial statements helps investors assess Monte Rosa's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Monte Rosa's valuation are summarized below:
Gross Profit
16.8 M
Market Capitalization
358.8 M
Enterprise Value Revenue
12.2637
Revenue
15 M
Earnings Share
(1.78)
There are over one hundred nineteen available fundamental ratios for Monte Rosa, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of Monte Rosa's last-minute performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of February 25, 2025, Market Cap is expected to decline to about 317.3 M. In addition to that, Enterprise Value is expected to decline to about 227.6 M
Check Monte Rosa financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Monte Rosa's main balance sheet or income statement drivers, such as Net Interest Income of 10.8 M, Depreciation And Amortization of 3.9 M or Interest Expense of 4.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.53. Monte financial statements analysis is a perfect complement when working with Monte Rosa Valuation or Volatility modules.
  
Check out the analysis of Monte Rosa Correlation against competitors.

Monte Rosa Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets236 M349.3 M109.9 M
Slightly volatile
Short and Long Term Debt Total44.4 M52.9 M19.5 M
Slightly volatile
Other Current Liabilities12.9 M16.8 M5.7 M
Slightly volatile
Total Current Liabilities26.9 M53.6 M15.1 M
Slightly volatile
Property Plant And Equipment Net75.6 M72 M18.9 M
Slightly volatile
Accounts Payable7.9 M12.8 M5.3 M
Slightly volatile
Cash126.9 M147.3 M56.6 M
Slightly volatile
Non Current Assets Total81.6 M77.7 M20.6 M
Slightly volatile
Cash And Short Term Investments195.6 M267.3 M87.9 M
Slightly volatile
Net Receivables551.7 K580.8 K1.1 M
Slightly volatile
Common Stock Total Equity4.3 K4.5 K32.8 K
Slightly volatile
Common Stock Shares Outstanding51.3 M59.1 M46.2 M
Slightly volatile
Liabilities And Stockholders Equity236 M349.3 M109.9 M
Slightly volatile
Non Current Liabilities Total46.9 M89.6 M32.5 M
Slightly volatile
Other Current Assets3.6 M3.8 M1.8 M
Slightly volatile
Other Stockholder Equity335.2 M630 M155.6 M
Slightly volatile
Total Liabilities73.8 M143.2 M47.6 M
Slightly volatile
Property Plant And Equipment Gross90.4 M86.1 M21.6 M
Slightly volatile
Short and Long Term Debt600 K675 K735.9 K
Slightly volatile
Total Current Assets201.1 M271.6 M92.2 M
Slightly volatile
Capital Stock4.3 K4.5 K32.8 K
Slightly volatile
Net Working Capital174.2 M218.1 M77.1 M
Slightly volatile
Short Term Debt3.7 M3.6 M2.3 M
Slightly volatile
Common Stock4.3 K4.5 K32.8 K
Slightly volatile
Property Plant Equipment32.7 M31.1 M9.3 M
Slightly volatile
Other Liabilities1.8 M1.8 M1.3 M
Slightly volatile
Non Currrent Assets Other3.2 M5.7 M2 M
Slightly volatile
Other Assets4.1 M5.3 M2.3 M
Slightly volatile
Capital Surpluse536.4 M579.3 M486.4 M
Slightly volatile
Non Current Liabilities Other26.2 M52.2 M12.2 M
Slightly volatile
Inventory768 K864 K942 K
Slightly volatile
Current Deferred Revenue14.1 M15.9 M17.3 M
Slightly volatile

Monte Rosa Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.9 M7.2 M2 M
Slightly volatile
Interest Expense4.5 M4.3 M1.1 M
Slightly volatile
Selling General Administrative38.7 M36.8 M10.1 M
Slightly volatile
Other Operating Expenses173 M164.8 M48.4 M
Slightly volatile
Research Development61.3 M120.8 M32.9 M
Slightly volatile
Cost Of Revenue3.9 M7.2 M1.8 M
Slightly volatile
Total Operating Expenses173 M164.8 M48.4 M
Slightly volatile
Reconciled Depreciation6.6 M6.3 M1.6 M
Slightly volatile
Interest Income10.8 M10.3 M2.1 M
Slightly volatile
Selling And Marketing Expenses7.6 M8.5 M9.3 M
Slightly volatile

Monte Rosa Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings7.2 M8.1 M8.8 M
Slightly volatile
Begin Period Cash Flow102.4 M69.2 M40.8 M
Slightly volatile
Other Cashflows From Financing Activities36.6 M24.7 M18.6 M
Slightly volatile
Depreciation7.5 M7.2 M1.8 M
Slightly volatile
Capital Expenditures23 M21.9 M6.5 M
Slightly volatile
Total Cash From Financing Activities23.5 M24.7 M42.7 M
Pretty Stable
End Period Cash Flow131.2 M152.6 M60.2 M
Slightly volatile
Change To Liabilities245.4 K258.3 K22.1 M
Slightly volatile
Cash Flows Other Operating800 K571.5 K1.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation3.343.5213.5378
Slightly volatile
Inventory Turnover7.148.028.7487
Slightly volatile
Days Of Inventory On Hand32.7536.8540.1719
Slightly volatile
Payables Turnover0.330.50.1939
Slightly volatile
Cash Per Share2.984.071.6802
Slightly volatile
Days Payables Outstanding71575210.6 K
Slightly volatile
Income Quality0.350.370.7073
Slightly volatile
Current Ratio6.54.564.5064
Slightly volatile
Graham Number8.4812.945.2496
Slightly volatile
Capex Per Share0.350.330.1203
Slightly volatile
Interest Debt Per Share0.70.810.3916
Slightly volatile
Debt To Assets0.170.15160.1759
Pretty Stable
Operating Cycle32.7536.8540.1719
Slightly volatile
Days Of Payables Outstanding71575210.6 K
Slightly volatile
Ebt Per Ebit1.131.081.006
Slightly volatile
Long Term Debt To Capitalization2.853.23.4929
Slightly volatile
Quick Ratio6.494.564.5034
Slightly volatile
Net Income Per E B T1.11.151.0345
Pretty Stable
Cash Ratio4.562.473.0075
Slightly volatile
Days Of Inventory Outstanding32.7536.8540.1719
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.981.291.2124
Pretty Stable
Debt Ratio0.170.15160.1759
Pretty Stable

Monte Rosa Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap317.3 M334 M781.4 M
Slightly volatile
Enterprise Value227.6 M239.6 M741 M
Slightly volatile

Monte Fundamental Market Drivers

Cash And Short Term Investments232.4 M

Monte Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Monte Rosa Financial Statements

Monte Rosa stakeholders use historical fundamental indicators, such as Monte Rosa's revenue or net income, to determine how well the company is positioned to perform in the future. Although Monte Rosa investors may analyze each financial statement separately, they are all interrelated. For example, changes in Monte Rosa's assets and liabilities are reflected in the revenues and expenses on Monte Rosa's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Monte Rosa Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue15.9 M14.1 M
Cost Of Revenue7.2 M3.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CRMSalesforce
CCitigroup
GMGeneral Motors
When determining whether Monte Rosa Therapeutics is a strong investment it is important to analyze Monte Rosa's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monte Rosa's future performance. For an informed investment choice regarding Monte Stock, refer to the following important reports:
How To Invest In Monte
Details
Is Monte Stock a good investment?
Details
What is Monte Rosa's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Monte Rosa Correlation against competitors.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monte Rosa. If investors know Monte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monte Rosa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.78)
Revenue Per Share
0.221
Return On Assets
(0.28)
Return On Equity
(0.61)
The market value of Monte Rosa Therapeutics is measured differently than its book value, which is the value of Monte that is recorded on the company's balance sheet. Investors also form their own opinion of Monte Rosa's value that differs from its market value or its book value, called intrinsic value, which is Monte Rosa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monte Rosa's market value can be influenced by many factors that don't directly affect Monte Rosa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY